ICD-10 category · Chapter VI · G70-G73
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere
9 codes under G73 in the South African Master Industry Table 2021, 8 valid for clinical use; 8 marked as a Prescribed Minimum Benefit; 2 on the Chronic Disease List.
| Code | Description | Use | Benefits |
|---|---|---|---|
| G73 * | Disorders of myoneural junction and muscle in diseases classified elsewhere | Heading only | — |
| G73.0 * | Myasthenic syndromes in endocrine diseases | Valid · not as primary | PMB 513A Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS · Initial diagnosis; initiation of medical management; therapy for acute complications and exacerbationsCDL Diabetes Mellitus Type 1, Diabetes Mellitus Type 2 |
| G73.1 * | Lambert-Eaton syndrome (C00-D48†) | Valid · not as primary | PMB 513A Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS · Initial diagnosis; initiation of medical management; therapy for acute complications and exacerbations |
| G73.2 * | Other myasthenic syndromes in neoplastic disease (C00-D48+) | Valid · not as primary | PMB 513A Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS · Initial diagnosis; initiation of medical management; therapy for acute complications and exacerbations |
| G73.3 * | Myasthenic syndromes in other diseases classified elsewhere | Valid · not as primary | PMB 513A Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS · Initial diagnosis; initiation of medical management; therapy for acute complications and exacerbations |
| G73.4 * | Myopathy in infectious and parasitic diseases classified elsewhere | Valid · not as primary | PMB 513A Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS · Initial diagnosis; initiation of medical management; therapy for acute complications and exacerbations |
| G73.5 * | Myopathy in endocrine diseases | Valid · not as primary | PMB 513A Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS · Initial diagnosis; initiation of medical management; therapy for acute complications and exacerbations |
| G73.6 * | Myopathy in metabolic diseases | Valid · not as primary | PMB 513A Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS · Initial diagnosis; initiation of medical management; therapy for acute complications and exacerbations |
| G73.7 * | Myopathy in other diseases classified elsewhere | Valid · not as primary | PMB 513A Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS · Initial diagnosis; initiation of medical management; therapy for acute complications and exacerbationsCDL Rheumatoid Arthritis |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.